Latest news with #AXGN
Yahoo
3 days ago
- Business
- Yahoo
Axogen Second Quarter 2025 Earnings: Beats Expectations
Explore Axogen's Fair Values from the Community and select yours Axogen (NASDAQ:AXGN) Second Quarter 2025 Results Key Financial Results Revenue: US$56.7m (up 18% from 2Q 2024). Net income: US$579.0k (up from US$1.92m loss in 2Q 2024). Profit margin: 1.0% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. EPS: US$0.013 (up from US$0.044 loss in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Axogen Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 7.7%. Earnings per share (EPS) also surpassed analyst estimates. Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US. Performance of the American Medical Equipment industry. The company's shares are up 9.7% from a week ago. Risk Analysis You should learn about the 1 warning sign we've spotted with Axogen. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Washington Post
08-05-2025
- Business
- Washington Post
AxoGen: Q1 Earnings Snapshot
ALACHUA, Fla. — ALACHUA, Fla. — AxoGen Inc. (AXGN) on Thursday reported a loss of $3.8 million in its first quarter. The Alachua, Florida-based company said it had a loss of 8 cents per share. Losses, adjusted for stock option expense, came to 2 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 1 cent per share.
